BBIO R&D to Revenue
Bridgebio Pharma Inc · R&D to Revenue
BBIO R&D to Revenue
Latest reported95.11%period ending
BBIO FY R&D/Revenue (0.00% → 95.11%)
Latest values, visible window
High-resolution chart · PNG
BBIO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 95.1119% | |
| 228.2363% | |
| 4,898.5381% | |
| 514.4524% | |
| 646.9447% | |
| 4,085.9134% | |
| 517.6208% | |
| 0% | |
| 0% |